[go: up one dir, main page]

MX2016014321A - Composiciones liquidas de liberacion prolongada de metformina. - Google Patents

Composiciones liquidas de liberacion prolongada de metformina.

Info

Publication number
MX2016014321A
MX2016014321A MX2016014321A MX2016014321A MX2016014321A MX 2016014321 A MX2016014321 A MX 2016014321A MX 2016014321 A MX2016014321 A MX 2016014321A MX 2016014321 A MX2016014321 A MX 2016014321A MX 2016014321 A MX2016014321 A MX 2016014321A
Authority
MX
Mexico
Prior art keywords
liquid compositions
extended release
release liquid
metformin
suspensions
Prior art date
Application number
MX2016014321A
Other languages
English (en)
Inventor
Kumar Ashish
Srikrishan Shear Rajesh
Kumar Jain Satish
Barat Singh Romi
P Jain Paras
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Publication of MX2016014321A publication Critical patent/MX2016014321A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona a composiciones líquidas de liberación prolongada de metformina. Las composiciones líquidas de liberación prolongada están en la forma de suspensiones o polvo reconstituido para suspensiones. Las composiciones líquidas de liberación prolongada comprenden núcleos de metformina recubiertos con un polímero de control de liberación, en donde los núcleos se dispersan en una base de suspensión. También se relaciona a procesos para la preparación de composiciones líquidas de liberación prolongada.
MX2016014321A 2014-05-01 2015-05-01 Composiciones liquidas de liberacion prolongada de metformina. MX2016014321A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1182DE2014 2014-05-01
PCT/IB2015/053207 WO2015166472A1 (en) 2014-05-01 2015-05-01 Extended release liquid compositions of metformin

Publications (1)

Publication Number Publication Date
MX2016014321A true MX2016014321A (es) 2017-05-23

Family

ID=54358255

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016014321A MX2016014321A (es) 2014-05-01 2015-05-01 Composiciones liquidas de liberacion prolongada de metformina.

Country Status (10)

Country Link
US (1) US20160228360A1 (es)
EP (1) EP3137057B1 (es)
AU (1) AU2015254874A1 (es)
CA (1) CA2947515A1 (es)
MA (1) MA42000A (es)
MX (1) MX2016014321A (es)
PL (1) PL3137057T3 (es)
RU (1) RU2016147008A (es)
WO (1) WO2015166472A1 (es)
ZA (1) ZA201607714B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
BR112017001968A2 (pt) 2014-07-30 2017-11-21 Sun Pharmaceutical Ind Ltd embalagem de duas câmaras para uma composição farmacêutica líquida oral de múltiplas doses
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
KR20200021774A (ko) * 2018-08-21 2020-03-02 대화제약 주식회사 시타글립틴 속방층을 포함하는 제제의 제조방법, 상기 제조방법으로 제조된 제제, 시타글립틴 속방층 코팅 방법, 및 시타글립틴 속방층 코팅용 조성물
WO2023084320A1 (en) * 2021-11-11 2023-05-19 V-Ensure Pharma Technologies Private Limited Reconstitutable, single use antidiabetic compositions
CN115227660B (zh) * 2022-09-21 2022-12-16 北京惠之衡生物科技有限公司 一种盐酸二甲双胍缓释片及其制备方法
WO2025120540A1 (en) * 2023-12-05 2025-06-12 Sun Pharmaceutical Industries Limited Method of reducing nitrosamine levels in pharmaceutical products and improved formulations thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273760A (en) * 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
DK1140027T3 (da) * 1998-12-23 2006-02-27 Alza Corp Doseringsformer indeholdende poröse partikler
DE60325709D1 (de) * 2002-04-09 2009-02-26 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
EP1549296A4 (en) * 2002-08-02 2006-08-09 Penwest Pharmaceuticals Co METFORMIN FORMULATIONS WITH DELAYED RELEASE
EP2242489A1 (en) * 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
JP2008538561A (ja) * 2005-04-20 2008-10-30 メルク エンド カムパニー インコーポレーテッド アンジオテンシンｉｉ受容体アンタゴニスト
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
CA2719342C (en) * 2008-02-29 2016-04-26 Pgt Photonics S.P.A Optical mode transformer, in particular for coupling an optical fiber and a high-index contrast waveguide
WO2010011466A2 (en) * 2008-06-27 2010-01-28 Otonomy, Inc. Controlled-release cns modulating compositions and methods for the treatment of otic disorders
WO2010045656A2 (en) * 2008-10-17 2010-04-22 Nectid, Inc. Novel sglt2 inhibitor dosage forms
EP2385823A4 (en) * 2009-01-09 2014-02-12 Panacea Biotec Ltd PHARMACEUTICAL SUSPENSION WITH DOUBLE RELEASE
WO2011107855A2 (en) * 2010-03-04 2011-09-09 Torrent Pharmaceuticals Limited Sustained release oral liquid suspension dosage form
EP2392319A1 (en) * 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs

Also Published As

Publication number Publication date
WO2015166472A1 (en) 2015-11-05
ZA201607714B (en) 2017-11-29
EP3137057A4 (en) 2017-12-13
AU2015254874A1 (en) 2016-11-17
CA2947515A1 (en) 2015-11-05
WO2015166472A9 (en) 2016-06-16
MA42000A (fr) 2018-03-07
RU2016147008A (ru) 2018-06-04
EP3137057B1 (en) 2020-09-09
EP3137057A1 (en) 2017-03-08
PL3137057T3 (pl) 2021-04-06
US20160228360A1 (en) 2016-08-11

Similar Documents

Publication Publication Date Title
MX2016014321A (es) Composiciones liquidas de liberacion prolongada de metformina.
ZA201604831B (en) Hybridosomes, compositions comprising the same, processes for their production and uses thereof
PL3137060T3 (pl) Kompozycje zawiesinowe o przedłużonym uwalnianiu
IL261046B (en) Substituted 1,2,3-triazoles as nr2b-selective nmda modulators
GB2556619B (en) Suspension compositions
EP3226839A4 (en) Gastroretentive extended release suspension compositions
PH12016501763B1 (en) Multispecific antibodies
SG11201703479SA (en) Substituted 2,4 diamino-quinoline as new anticancer agents
GB201617759D0 (en) Nanocage
WO2015191945A3 (en) Solid state forms of sofosbuvir
HUE071679T2 (hu) Szemészeti szuszpenziós készítmény
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
GB201513020D0 (en) Radiation-curable compositions, membranes and the manufacture and use of such membranes
PT3298894T (pt) Suspensão de microcápsula
NZ725578A (en) Modified release coated capsules
WO2016109361A3 (en) 3-fluoro-benzonitrile inhibitors of 11-beta-hydroxylase
GB201515296D0 (en) Hydrogel compositions, methods for preparing the same and uses thereof
EP3212699A4 (en) Suspension polymerization compositions, methods and use thereof
GB2570376B (en) Suspension compositions
PL3233126T3 (pl) Nanocząstki do enkapsulacji związków, ich przygotowanie i zastosowania
IL251229A0 (en) Process for preparing 5-bromo-1,2,3-trichlorobenzene
PT3735962T (pt) Composição farmacêutica que compreende partículas de quelante de fosfato
PT3470059T (pt) Composição de suspensão oftálmica
TH149082B (th) องค์ประกอบชนิดใหม่,การเตรียมของสารเหล่านี้ และการใช้ของสารเหล่านี้สำหรับผลิตโพลีเอไมด์ที่เป็นตัวหล่อ